解毒散结方联合中药静脉制剂对晚期非小 细胞肺癌患者的临床疗效
摘要
关键词
全文:
PDF参考
[1]诸君,张国磊,韩力,等. 解毒散结方联合中药静脉制剂对晚期非小细胞肺癌患者的临床疗效[J]. 中成药,2022,44(9):
2843-2847.
[2]尤建良,阮纪恺.中药宁肺散结方联合 GP 方案治疗晚期非小细胞肺癌的临床研究[J].辽宁中医杂志,2021,39(10):458-461.
[3]Mao-Sheng W,Shu-Lian Y,Wei H .Clinical Effect of Yiqijieduhuoxue Prescription Combined with Chemotherapy on Qual
ity of Life of Adult AML Patients[J].Journal of Emergency in Traditional Chinese Medicine,2022,7(13):274-276.
[4]陆晔,陈美云,许尤琪. "益肺散结方"联合化疗治疗晚期肺癌 30 例临床研究[J]. 江苏中医药,2021,49(3):32-35.
[5]Hong-Guang Z,Hai-Bin C,Mian-Hua W U,et al.Clinical observation of Xiao'ai Jiedu Prescription combined with chemo
therapy on advanced cancer[J].China Journal of Traditional Chinese Medicine & Pharmacy,2021,9(14):123-125.
[6]杨雪飞,叶知锋,郭丽丽,等. 益气养阴散结方联合 EGFR-TKIs 治疗 EGFR-TKIs 继发耐药的晚期非小细胞肺癌的临床疗
效观察[J]. 中国中医药科技,2021,26(3):386-388.
[7]王剑锋,卢涛,周天,等. 基于数据挖掘的中医药协同化疗治疗晚期非小细胞肺癌的用药规律分析[J]. 现代中西医结合杂
志,2021,30(18):2016-2019,2030.
[8]Li R,Zhuang A,Ma J,et al.Effect of Jieduquyuziyin prescription-treated rat serum on MeCP2 gene expression in Jurkat
T cells[J].In Vitro Cellular & Developmental Biology - Animal,2021,5(8):54-56.
[9]陆兵,吕红,余静,等.扶正解毒抗癌方联合化疗治疗晚期非小细胞肺癌 30 例临床研究[J].医药前沿,2021,9(5):115-117.
[10]Liu L S,Shen L P,Jiang Y,et al.[Effect of integrated Chinese medical treatment(as maintenance therapy)on the survi
val time of patients with advanced non-small-cell lung cancer:a clinical study].[J].Chinese Journal of Integrated Traditional a
nd Western Medicine,2021,34(5):526-530.
[11]樊佳. 扶正散结方联合 GP 化疗治疗晚期非小细胞肺癌患者的临床研究[J]. 首都食品与医药,2020,27(4):199-200.
[12]张国磊,诸君,韩力,等. 解毒散结方辅助治疗晚期非小细胞肺癌临床研究[J]. 中国中医药信息杂志,2021,28(9):1
11-116.
[13]王建平,魏品康,耿怀成.解毒散结方联合化疗治疗中晚期肺癌 30 例观察[J]. 实用中医药杂志,2021,23(3):177-178.
[14]刘源,王淑玲.补肾散结方联合 GP 方案治疗晚期非小细胞肺癌临床疗效观察[J].中华中医药杂志,2021,26(4):864-867.
[15]Zongquan T .Clinical Observation of Applying Huazhuo Jiedu Prescription Combined with Triple Therapy in the Treatment
of Gastric Ulcer[J].Journal of Sichuan of Traditional Chinese Medicine,2021,9(56):128-130.
(10 摘要 Views, 60 PDF Downloads)
Refbacks
- 当前没有refback。